본문 바로가기
KERD
논문KCI 등재

Time-Lag between Subretinal Fluid and Pigment Epithelial Detachment Reduction after Polypoidal Choroidal Vasculopathy Treatment

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류안과학

초록

Purpose: The goal of the present research was to study post-treatment changes in polypoidal choroidal vasculopathy (PCV) shown by optical coherence tomography (OCT). Methods: The study included 12 patients with naive PCV. Photodynamic therapy and 3 consecutive intravitreal bevacizumab injections at 6-week intervals were given. Best corrected visual acuity, subretinal fluid (SRF), pigment epithelium detachment (PED), central macular thickness (CMT), and total macular volume (TMV) were measured before and after treatment as assessed by Stratus OCT3. Results: After treatment, the SRF height decreased earlier than the PED height. The SRF diameter decreased with statistical significance. However, the PED diameter did not show a statistically significant improvement, persisting at pre-treatment levels. Both CMT and TMV decreased significantly after treatment. Conclusions: After PCV treatment, SRF and PED stabilized, as shown by OCT. However, the PED treatment response was both delayed and refractory compared to the SRF response. The small change in post-treatment PED diameter may suggest the possibility of PCV recurrence.

Abstract

Purpose: The goal of the present research was to study post-treatment changes in polypoidal choroidal vasculopathy (PCV) shown by optical coherence tomography (OCT). Methods: The study included 12 patients with naive PCV. Photodynamic therapy and 3 consecutive intravitreal bevacizumab injections at 6-week intervals were given. Best corrected visual acuity, subretinal fluid (SRF), pigment epithelium detachment (PED), central macular thickness (CMT), and total macular volume (TMV) were measured before and after treatment as assessed by Stratus OCT3. Results: After treatment, the SRF height decreased earlier than the PED height. The SRF diameter decreased with statistical significance. However, the PED diameter did not show a statistically significant improvement, persisting at pre-treatment levels. Both CMT and TMV decreased significantly after treatment. Conclusions: After PCV treatment, SRF and PED stabilized, as shown by OCT. However, the PED treatment response was both delayed and refractory compared to the SRF response. The small change in post-treatment PED diameter may suggest the possibility of PCV recurrence.

참고문헌 (28)

  1. Spaide RF, "Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy", Retina, 15, pp.100~110 (1995)
  2. Yannuzzi LA, "The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy", Arch Ophthalmol, 115, pp.478~485 (1997)
  3. Yuzawa M, "The origins of polypoidal choroidal vasculopathy", Br J Ophthalmol, 89, pp.602~607 (2005)
  4. Uyama M, "Idiopathic polypoidal choroidal vasculopathy in Japanese patients", Arch Ophthalmol, 117, pp.1035~1042 (1999)
  5. Uyama M, "Polypoidal choroidal vasculopathy:natural history", Am J Ophthalmol, 133, pp.639~648 (2002)
  6. Yannuzzi LA, "Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration", Arch Ophthalmol, 117, pp.1503~1510 (1999)
  7. Moorthy RS, "Idiopathic polypoidal choroidal vasculopathy of the macula", Ophthalmology, 105, pp.1380~1385 (1998)
  8. Costa RA, "Polypoidal choroidal vasculopathy:angiographic characterization of the network vascular elements and a new treatment paradigm", Prog Retin Eye Res, 24, pp.560~586 (2005)
  9. Ciardella AP, "Polypoidal choroidal vasculopathy", Surv Ophthalmol, 49, pp.25~37 (2004)
  10. Tateiwa H, "Polypoidal choroidal vasculopathy with large vascular network", Graefes Arch Clin Exp Ophthalmol, 240, pp.354~361 (2002)
  11. Yannuzzi LA, "Indocyanine green angiography", pp.329~339 (1997), Mosby
  12. Kwok AK, "Polypoidal choroidal vasculopathy in Chinese patients", Br J Ophthalmol, 86, pp.892~897 (2002)
  13. Sho K, "Polypoidal choroidal vasculopathy:incidence,demographic features,and clinical characteristics", Arch Ophthalmol, 121, pp.1392~1396 (2003)
  14. Yannuzzi LA, "Idiopathic polypoidal choroidal vasculopathy:a peripheral lesion", Arch Ophthalmol, 116, pp.382~383 (1998)
  15. Gomez-Ulla F, "Diode laser photocoagulation in idiopathic polypoidal choroidal vasculopathy", Retina, 18, pp.481~483 (1998)
  16. Yuzawa M, "A study of laser photocoagulation for polypoidal choroidal vasculopathy", Jpn J Ophthalmol, 47, pp.379~384 (2003)
  17. Nishijima K, "Laser photocoagulation of indocyanine green angiographically identified feeder vessels to idiopathic polypoidal choroidal vasculopathy", Am J Ophthalmol, 137, pp.770~773 (2004)
  18. Akaza E, "Long-term results of photodynamic therapy of polypoidal choroidal vasculopathy", Retina, 28, pp.717~722 (2008)
  19. Lee SC, "Photodynamic therapy with verteporfin for polypoidal choroidal vasculopathy of the macula", OPHTHALMOLOGICA, 218(3), pp.193~201
  20. Gomi F, "One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients", Ophthalmology, 115, pp.141~146 (2008)
  21. Hussain N, "Role of photodynamic therapy in polypoidal choroidal vasculopathy", Indian J Ophthalmol, 53, pp.101~104 (2005)
  22. Spaide RF, "Treatment of polypoidal choroidal vasculopathy with photodynamic therapy", Retina, 22, pp.529~535 (2002)
  23. Silva RM, "Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin", Graefes Arch Clin Exp Ophthalmol, 243, pp.973~979 (2005)
  24. Chan WM, "Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy:one-year results of a prospective case series", Ophthalmology, 111, pp.1576~1584 (2004)
  25. Sato T, "Tomographic features of branching vascular networks in polypoidal choroidal vasculopathy", Retina, 27, pp.589~594 (2007)
  26. Tsujikawa A, "Pigment epithelial detachment in polypoidal choroidal vasculopathy", Am J Ophthalmol, 143, pp.102~111 (2007)
  27. 이혜련, "Photodynamic therapy for polypoidal choroidal vasculopathy: Vaso-occlusive effect on the branching vascular network and origin of recurrence", JAPANESE JOURNAL OF OPHTHALMOLOGY, 52, pp.108~115, SPRINGER TOKYO
  28. Yamashiro K, "Recurrence of polypoidal choroidal vasculopathy after photodynamic therapy", Jpn J Ophthalmol, 52, pp.457~462 (2008)

관련 논문AI추천

The Therapeutic Effects of Bevacizumab in Patients with Polypoidal Choroidal Vasculopathy정혜원, June­Gone Kim, Soo Geun Joe, Sun Young Lee, Young Hee Yoon대한안과학회 · Korean Journal of Ophthalmology2008 · 제22권 제2호One-year Results of Aflibercept Treatment for Polypoidal Choroidal Vasculopathy with Good Visual Acuity권지민, 김현웅, 박강윤, 사공민, 이재정대한안과학회 · Korean Journal of Ophthalmology2021 · 제35권 제1호Peripapillary Choroidal Thickness Change of Polypoidal Choroidal Vasculopathy after Anti-vascular Endothelial Growth Factor강의천, 고형준, 김서희, 이규호, 이지민대한안과학회 · Korean Journal of Ophthalmology2017 · 제31권 제5호Intravitreal Anti-vascular Endothelial Growth Factor for Newly Diagnosed Symptomatic Polypoidal Choroidal Vasculopathy with Extrafoveal Polyps김재휘, 김종우, 김철구, 이동원, 이태곤, 조한주, 최성찬대한안과학회 · Korean Journal of Ophthalmology2015 · 제29권 제6호Short-term Effectiveness of Intravitreal Bevacizumab vs. Ranibizumab Injections for Patients with Polypoidal Choroidal Vasculopathy김종우, 김철구, 백지선, 이동원, 조한주대한안과학회 · Korean Journal of Ophthalmology2012 · 제26권 제3호Intravitreal Anti-vascular Endothelial Growth Factor for Treating Polypoidal Choroidal Vasculopathy with Grape-like Polyp ClustersChul Gu Kim, Jae Hui Kim, Jong Woo Kim, Tae Gon Lee, Young Suk Chang대한안과학회 · Korean Journal of Ophthalmology2016 · 제30권 제4호

이 간행물의 다른 논문 (14건)